Eli Lilly, Shares in Novo Nordisk
Digest more
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
Stream Connecticut News for free, 24/7, wherever you are. A previous update said some doses of the treatments were still in short supply. Some doses of Mounjaro have been in shortage since as early ...
Baillies, a human resources specialist based in Milwaukee, Wisconsin, has been attempting to lose weight and dealing with chronic autoimmune issues for years, so she turned to a cheaper alternative: ...
A Delaware federal judge dismissed a lawsuit brought by Eli Lilly, the maker of the blockbuster weight loss drugs Mounjaro and Zepbound, against a telehealth company it accused of “deceptive” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results